サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1455184

生物イメージング試薬の世界市場レポート 2024年

Biologic Imaging Reagents Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
生物イメージング試薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

生物イメージング試薬の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.7%の年間複合成長率（CAGR）で257億2,000万米ドルに成長すると予想されます。予測期間で予想される成長は、医薬品開発における用途の拡大、分子イメージングの需要の増加、非侵襲的診断方法への集中、がん症例の世界の増加、価値ベースのヘルスケアへの移行によるものと考えられます。予測期間中に予想される重要な動向には、造影イメージング剤の需要の高まり、標的分子イメージング剤の開発、イメージングにおけるナノ粒子の応用、生体内イメージング用の蛍光プローブの出現、および人工画像の統合が含まれます。画像解析におけるインテリジェンス。

慢性疾患の有病率の上昇が生物イメージング試薬市場の成長を促進すると予想されます。 1年以上続き、継続的な医師の診察が必要な慢性疾患では、多くの場合、影響を受けた臓器や構造を視覚化することで疾患を診断および検出するために生物イメージング試薬が必要になります。米国がん協会は、2022年に米国で推定190万人の新たながん症例と609,360人のがんによる死亡を報告しました。さらに、IDF糖尿病アトラス第10版2021では、2021年に世界中で5億3,700万人の糖尿病患者が報告されており、2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。慢性疾患の有病率の高まりは、生物イメージング試薬市場の成長の主な原動力です。

個別化医療に対する需要の高まりは、生物イメージング試薬市場の成長に寄与すると予想されます。個別化医療では、生物イメージング試薬を利用して生物学的プロセスを分子および細胞レベルで視覚化し、ヘルスケアの決定と治療を個々の患者の特性に合わせて調整します。 2022年、食品医薬品局の医薬品評価研究センターは37の新しい分子実体を承認し、そのうち約34%（12）が個別化医療連合によって個別化医療として分類されました。この個別化医療に対する需要の高まりが、生物イメージング試薬市場を牽引する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の生物イメージング試薬市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の生物イメージング試薬の市場規模実績と成長、2018年～2023年
  • 世界の生物イメージング試薬市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の生物イメージング試薬市場、製品別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 造影剤
  • 光学イメージング試薬
  • 放射性医薬品
  • 世界の生物イメージング試薬市場、モダリティ別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 磁気共鳴画像法（MRI）
  • 超音波
  • X線とコンピュータ断層撮影（CT）
  • 核
  • 光学イメージング
  • その他のモダライト
  • 世界の生物イメージング試薬市場、用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 試験管内
  • 生体内
  • 世界の生物イメージング試薬市場、エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 診断研究所
  • 画像センター
  • ライフサイエンス企業
  • 研究および学術機関
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の生物イメージング試薬市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界の生物イメージング試薬市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 生物イメージング試薬市場の競合情勢
  • 生物イメージング試薬市場の企業プロファイル
    • Cardinal Health Inc.
    • Johnson And Johnson Services Inc.
    • Bayer Healthcare AG
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare GmbH

第31章 その他の主要および革新的な企業

  • Dickinson and Company（BD）
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Stryker Corporation
  • FluoroPharma Medical Inc.
  • Lonza Group AG
  • Illumina Inc.
  • PerkinElmer Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Bracco Diagnostics Inc.
  • Leica Microsystems GmbH
  • Lantheus Medical Imaging Inc.
  • Guerbet SA
  • Miltenyi Biotec BV and Co. KG

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16185

Biologic imaging reagents encompass substances or compounds employed in diverse imaging techniques to augment the visibility and contrast of biological structures, molecules, or processes. These reagents are specifically designed to interact with distinct biological targets, such as proteins, nucleic acids, or cellular structures, thereby enhancing their visibility and distinguishability during imaging.

The primary categories of products within biologic imaging reagents include contrast reagents, optical imaging reagents, and radiopharmaceuticals. Contrast reagents are substances utilized in medical imaging to amplify the visibility of specific tissues. This encompasses various modalities such as magnetic resonance imaging (MRI), ultrasound, x-ray, and computerized tomography (CT), nuclear, optical, and others, applied in various contexts, including in vitro and in vivo. Diagnostic laboratories, imaging centers, life science companies, research and academic institutes, and other entities make use of these reagents.

The biologic imaging reagents market research report is one of a series of new reports from The Business Research Company that provides biologic imaging reagents market statistics, including biologic imaging reagents industry global market size, regional shares, competitors with a biologic imaging reagents market share, detailed biologic imaging reagents market segments, market trends and opportunities, and any further data you may need to thrive in the biologic imaging reagents industry. This biologic imaging reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologic imaging reagents market size has grown rapidly in recent years. It will grow from $16.69 billion in 2023 to $18.41 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The increase observed during the historical period can be credited to the upsurge in the prevalence of chronic diseases, heightened investments in research and development, a shift towards personalized medicine, emphasis on early disease detection, a growing geriatric population, and collaborative efforts in biomedical research.

The biologic imaging reagents market size is expected to see strong growth in the next few years. It will grow to $25.72 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period can be ascribed to the broadening applications in drug development, an increasing demand for molecular imaging, a concentration on non-invasive diagnostic methods, a global rise in cancer cases, and a shift towards value-based healthcare. Significant trends expected in the forecast period involve an upswing in the demand for contrast-enhanced imaging agents, the development of targeted molecular imaging agents, the application of nanoparticles in imaging, the emergence of fluorescent probes for in vivo imaging, and the integration of artificial intelligence in image analysis.

The rise in the prevalence of chronic diseases is expected to drive the growth of the biologic imaging reagents market. Chronic diseases, lasting one year or longer and necessitating continuous medical attention, often require biologic imaging reagents for the diagnosis and detection of diseases by visualizing affected organs and structures. In 2022, the American Cancer Society reported an estimated 1.9 million new cancer cases and 609,360 cancer deaths in the United States. Additionally, the IDF Diabetes Atlas Tenth Edition 2021 reported 537 million individuals with diabetes globally in 2021, projected to increase to 643 million by 2030 and 783 million by 2045. The escalating prevalence of chronic diseases is a key driver of the biologic imaging reagents market's growth.

The increasing demand for personalized medicine is anticipated to contribute to the growth of the biologic imaging reagents market. Personalized medicine tailors healthcare decisions and treatments to individual patient characteristics, utilizing biologic imaging reagents to visualize biological processes at the molecular and cellular level. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research approved 37 new molecular entities, with approximately 34% (12) classified as personalized medicines by the Personalized Medicine Coalition. This growing demand for personalized medicine is a significant factor driving the biologic imaging reagents market.

The high cost of laboratory reagents is expected to impede the growth of the biologic imaging reagents market. Elevated reagent costs may pose accessibility barriers and limit patient adoption due to financial constraints. In May 2021, laboratory reagent prices ranged from $47 to $1,250, according to Bimedis, an online medical equipment trading platform. The high cost of reagents can be a potential hindrance to the biologic imaging reagents market.

Major players in the biologic imaging reagents market are dedicating their efforts to the development of innovative reagents, particularly novel dye technology, providing a new tool for researchers and clinicians to enhance the sensitivity and specificity of biologic imaging. Novel dye technology involves the creation of new dyes for various applications, including biological imaging. In April 2022, Becton, Dickinson, and Company, a US-based medical device company, introduced BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new line of reagents enables researchers to obtain higher data resolution and more insights from samples compared to standard fluorochrome. The improvement is attributed to the incorporation of revolutionary dye technology and artificial intelligence (AI) supervision. The AI analyzed existing data from excitation and emission profiles of commercially available fluorochromes, determining optimal positions in laser lines for the development of novel dyes.

In September 2021, PerkinElmer Inc., a US-based technology and service solutions provider, completed the acquisition of BioLegend Inc. for $5.25 billion. Through this acquisition, PerkinElmer aims to broaden its product portfolio, reinforce its commitment to innovation, and facilitate the growth of its life science business to better serve customers and partners. BioLegend Inc., a US-based biotechnology company, specializes in providing antibodies, proteins, and other reagents for research and diagnostics.

Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Wurttemberg GmbH, ABX Advanced Biochemical Compounds GmbH

North America was the largest region in the biologic imaging reagents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologic imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologic imaging reagents market consists of sales of gadolinium-based contrast agents, iodinated contrast agents, microbubbles, nanoparticles, bioluminescent probes, immunohistochemistry reagents, optical imaging agents, paramagnetic agents and fluorescent dyes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologic Imaging Reagents Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologic imaging reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologic imaging reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologic imaging reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Contrast Reagents; Optical Imaging Reagents; Radiopharmaceuticals
  • 2) By Modality: Magnetic Resonance Imaging (MRI); Ultrasound; X-Ray And Computerized Tomography (CT); Nuclear; Optical Imaging; Other Modalities
  • 3) By Application: In Vitro; In Vivo
  • 4) By End User: Diagnostic Laboratories; Imaging Centers; Life Science Companies; Research And Academic Institutes; Other End Users
  • Companies Mentioned: Cardinal Health Inc.; Johnson And Johnson Services Inc.; Bayer Healthcare AG; Thermo Fisher Scientific Inc.; Siemens Healthcare GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologic Imaging Reagents Market Characteristics

3. Biologic Imaging Reagents Market Trends And Strategies

4. Biologic Imaging Reagents Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biologic Imaging Reagents Market Size and Growth

  • 5.1. Global Biologic Imaging Reagents Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biologic Imaging Reagents Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biologic Imaging Reagents Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biologic Imaging Reagents Market Segmentation

  • 6.1. Global Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contrast Reagents
  • Optical Imaging Reagents
  • Radiopharmaceuticals
  • 6.2. Global Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • X-Ray And Computerized Tomography (CT)
  • Nuclear
  • Optical Imaging
  • Other Modalites
  • 6.3. Global Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In Vitro
  • In Vivo
  • 6.4. Global Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic Laboratories
  • Imaging Centers
  • Life Science Companies
  • Research And Academic Institutes
  • Other End Users

7. Biologic Imaging Reagents Market Regional And Country Analysis

  • 7.1. Global Biologic Imaging Reagents Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biologic Imaging Reagents Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biologic Imaging Reagents Market

  • 8.1. Asia-Pacific Biologic Imaging Reagents Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biologic Imaging Reagents Market

  • 9.1. China Biologic Imaging Reagents Market Overview
  • 9.2. China Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biologic Imaging Reagents Market

  • 10.1. India Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biologic Imaging Reagents Market

  • 11.1. Japan Biologic Imaging Reagents Market Overview
  • 11.2. Japan Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biologic Imaging Reagents Market

  • 12.1. Australia Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biologic Imaging Reagents Market

  • 13.1. Indonesia Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biologic Imaging Reagents Market

  • 14.1. South Korea Biologic Imaging Reagents Market Overview
  • 14.2. South Korea Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biologic Imaging Reagents Market

  • 15.1. Western Europe Biologic Imaging Reagents Market Overview
  • 15.2. Western Europe Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biologic Imaging Reagents Market

  • 16.1. UK Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biologic Imaging Reagents Market

  • 17.1. Germany Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biologic Imaging Reagents Market

  • 18.1. France Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biologic Imaging Reagents Market

  • 19.1. Italy Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biologic Imaging Reagents Market

  • 20.1. Spain Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biologic Imaging Reagents Market

  • 21.1. Eastern Europe Biologic Imaging Reagents Market Overview
  • 21.2. Eastern Europe Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biologic Imaging Reagents Market

  • 22.1. Russia Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biologic Imaging Reagents Market

  • 23.1. North America Biologic Imaging Reagents Market Overview
  • 23.2. North America Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biologic Imaging Reagents Market

  • 24.1. USA Biologic Imaging Reagents Market Overview
  • 24.2. USA Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biologic Imaging Reagents Market

  • 25.1. Canada Biologic Imaging Reagents Market Overview
  • 25.2. Canada Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biologic Imaging Reagents Market

  • 26.1. South America Biologic Imaging Reagents Market Overview
  • 26.2. South America Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biologic Imaging Reagents Market

  • 27.1. Brazil Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biologic Imaging Reagents Market

  • 28.1. Middle East Biologic Imaging Reagents Market Overview
  • 28.2. Middle East Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biologic Imaging Reagents Market

  • 29.1. Africa Biologic Imaging Reagents Market Overview
  • 29.2. Africa Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biologic Imaging Reagents Market Competitive Landscape And Company Profiles

  • 30.1. Biologic Imaging Reagents Market Competitive Landscape
  • 30.2. Biologic Imaging Reagents Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson And Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer Healthcare AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthcare GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Biologic Imaging Reagents Market Other Major And Innovative Companies

  • 31.1. Dickinson and Company (BD)
  • 31.2. Koninklijke Philips N.V.
  • 31.3. GE HealthCare Technologies Inc.
  • 31.4. Stryker Corporation
  • 31.5. FluoroPharma Medical Inc.
  • 31.6. Lonza Group AG
  • 31.7. Illumina Inc.
  • 31.8. PerkinElmer Inc.
  • 31.9. Becton, Dickinson and Company
  • 31.10. Bio-Rad Laboratories Inc.
  • 31.11. Bracco Diagnostics Inc.
  • 31.12. Leica Microsystems GmbH
  • 31.13. Lantheus Medical Imaging Inc.
  • 31.14. Guerbet SA
  • 31.15. Miltenyi Biotec B.V. and Co. KG

32. Global Biologic Imaging Reagents Market Competitive Benchmarking

33. Global Biologic Imaging Reagents Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biologic Imaging Reagents Market

35. Biologic Imaging Reagents Market Future Outlook and Potential Analysis

  • 35.1 Biologic Imaging Reagents Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Biologic Imaging Reagents Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Biologic Imaging Reagents Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer